XML 68 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure - USD ($) | 5 Months Ended | 7 Months Ended | 12 Months Ended
--- | --- | --- | ---
May 31, 2022 | Dec. 31, 2022 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Pay vs Performance Disclosure |  |  |  |  |  |  |
Pay vs Performance Disclosure, Table |  |  | Pay Versus Performance As required by SEC rules, we are providing the information below about the relationship between executive compensation, as computed in accordance with SEC rules, and certain measures of the Company’s financial performance. For further information concerning the Company’s pay for performance philosophy and how the Company’s aligns executive compensation with the Company’s performance, please see the “Compensation Discussion and Analysis” (“CD&A”) section of this proxy statement. Pay versus Performance Table
| Fiscal Year |  |  | Summary Compensation Table Total for PEO1(1)(2) |  |  | Summary Compensation Table Total for PEO2(1)(2) |  |  | Compensation Actually Paid to PEO1(1)(3)(4)(5) |  |  | Compensation Actually Paid to PEO2(1)(3)(4)(5) |  |  | Average Summary Compensation Table Total for Non-PEO NEOs(2) |  |  | Average Compensation Actually Paid to Non-PEO NEOs(3)(4)(5) |  |  | Value of Initial Fixed $100 Investment Based on: |  |  | Net Income (in millions) |  |  | Adjusted Revenue(6) (in millions) |
| Total Shareholder Return |  |  | Peer Group Total Shareholder Return |
| 2024 |  |  | $13,302,350 |  |  | N/A |  |  | $32,707,769 |  |  | N/A |  |  | $3,341,659 |  |  | $6,553,447 |  |  | $152.49 |  |  | $105.42 |  |  | $418.3 |  |  | $2,074.1 |
| 2023 |  |  | $12,379,765 |  |  | N/A |  |  | $12,803,863 |  |  | N/A |  |  | $2,840,156 |  |  | $351,212 |  |  | $126.74 |  |  | $106.34 |  |  | $206.3 |  |  | $1,689.3 |
| 2022 |  |  | $10,817,028 |  |  | $15,711,252 |  |  | $16,062,320 |  |  | $13,495,700 |  |  | $3,375,872 |  |  | $4,244,342 |  |  | $171.96 |  |  | $99.81 |  |  | $4.6 |  |  | $1,331.0 |
| 2021 |  |  | N/A |  |  | $9,723,273 |  |  | N/A |  |  | $9,120,882 |  |  | $2,585,706 |  |  | $2,613,046 |  |  | $155.41 |  |  | $125.43 |  |  | $16.8 |  |  | $1,091.9 |
| 2020 |  |  | N/A |  |  | $7,275,332 |  |  | N/A |  |  | $18,855,662 |  |  | $2,363,796 |  |  | $5,370,327 |  |  | $149.32 |  |  | $130.04 |  |  | $6.8 |  |  | $897.0 |
(1) | During 2022, both Mr. Hollingshead and Ms. Petrovic served as Insulet’s Principal Executive Officer (PEO) for a portion of the year. Mr. Hollingshead (“PEO1”) served as PEO from June 1, 2022 to April 28, 2025 and Ms. Petrovic (PEO2) served as PEO in 2020, 2021, and, from January 1, 2022 to June 1, 2022.
(2) | These amounts represent compensation set forth in the “Total” column of the Summary Compensation Table for our PEO and an average of the Summary Compensation totals for the following named executive officers (“NEOs”) for the years indicated:
| Year |  |  | PEO |  |  | Non-PEO NEOs |
| 2024 |  |  | James Hollingshead |  |  | Ana Chadwick, Eric Benjamin, John Kapples, Mark Field, Lauren Budden |
| 2023 |  |  | James Hollingshead |  |  | Lauren Budden, Eric Benjamin, John Kapples, Mark Field, Wayde McMillan, Bret Christensen |
| 2022 |  |  | James Hollingshead Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, Eric Benjamin |
| 2021 |  |  | Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, John Kapples |
| 2020 |  |  | Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, Dan Manea |
(3) | Amounts represent “compensation actually paid” as computed in accordance with SEC rules to our PEO and the average “compensation actually paid”, also as computed in accordance with SEC rules, to the remaining NEOs for the years indicated above. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the executives during the applicable years. For information regarding the decisions made by our Talent and Compensation Committee relating to executive compensation, see the “Compensation Discussion and Analysis” section of this proxy statement.
(4) | The table below reflects the amounts deducted and added to the Summary Compensation Table total compensation in order to determine compensation actually paid, as defined and computed in accordance with SEC rules.
| Executive |  |  | Fiscal Year |  |  | Total Reported in Summary Compensation Table |  |  | - Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year |  |  | + Fair Value at Fiscal Year- End of Outstanding and Unvested Option Awards and Stock Awards Granted in 2024 |  |  | + Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years |  |  | + Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year |  |  | - Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions during Fiscal Year(a) |  |  | Compensation Actually Paid |
| James Hollingshead (CEO/PEO)(b) |  |  | 2024 |  |  | $13,302,350 |  |  | ($10,249,856) |  |  | $25,478,850 |  |  | $4,713,605 |  |  | ($537,180) |  |  | $0 |  |  | $32,707,769 |
|  |  |  | 2023 |  |  | $12,379,765 |  |  | ($9,499,797) |  |  | $11,615,643 |  |  | ($1,533,273) |  |  | ($158,475) |  |  | $0 |  |  | $12,803,863 |
|  |  |  | 2022 |  |  | $10,817,028 |  |  | ($8,999,878) |  |  | $14,245,170 |  |  | $0 |  |  | $0 |  |  | $0 |  |  | $16,062,320 |
| Shacey Petrovic (PEO2) |  |  | 2022 |  |  | $15,711,252 |  |  | ($14,006,044) |  |  | $11,115,887 |  |  | $1,586,091 |  |  | ($911,486) |  |  | $0 |  |  | $13,495,700 |
|  |  |  | 2021 |  |  | $9,723,273 |  |  | ($7,999,379) |  |  | $7,011,866 |  |  | ($692,234) |  |  | ​$1,077,356 |  |  | $0 |  |  | $9,120,882 |
|  |  |  | 2020 |  |  | $7,275,332 |  |  | ($5,476,105) |  |  | $7,347,782 |  |  | $6,876,682 |  |  | $2,831,971 |  |  | $0 |  |  | $18,855,662 |
| Average for Other NEOs |  |  | 2024 |  |  | $3,341,659 |  |  | ($2,289,749) |  |  | $5,179,609 |  |  | $443,080 |  |  | ($121,153) |  |  | $0 |  |  | $6,553,447 |
|  |  |  | 2023 |  |  | $2,840,156 |  |  | ($1,835,437) |  |  | $1,003,036 |  |  | ($240,497) |  |  | $115,240 |  |  | ($1,531,286) |  |  | $351,212 |
|  |  |  | 2022 |  |  | $3,375,872 |  |  | ($2,274,727) |  |  | $2,984,865 |  |  | $450,758 |  |  | ($292,425) |  |  | $0 |  |  | $4,244,342 |
|  |  |  | 2021 |  |  | $2,585,706 |  |  | ($1,674,745) |  |  | $1,484,500 |  |  | ($55,242) |  |  | $272,828 |  |  | $0 |  |  | $2,613,046 |
|  |  |  | 2020 |  |  | $2,363,796 |  |  | ($1,418,526) |  |  | $1,934,038 |  |  | $2,034,349 |  |  | $456,672 |  |  | $0 |  |  | $5,370,327 |
(a) | Messrs. Christensen and McMillan left the Company on May 5, 2023 and October 20, 2023, respectively. Their outstanding unvested stock awards and option awards were forfeited in 2023 and will not be realized.
(b) | Mr. Hollingshead left the Company in April 2025.
(5) | Equity values used to determine the deductions and additions set forth in the tables in note 4 above to calculate “compensation actually paid” for our CEO/PEO and average “compensation actually paid” for our other NEOs are calculated in accordance with ASC 718. Adjustments with respect to stock option awards have been made as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term volatility and risk-free rates) as of the relevant measurement date in accordance with U.S. GAAP. Adjustments with respect to the PSUs is based on both the stock price as of the measurement date as well as our estimate of the probable outcome of the performance conditions applicable to each PSU award.
(6) | Adjusted revenue is Insulet’s self-selected most important financial metric used to determine compensation actually paid in the most recent fiscal year. Adjusted revenue, which is a non-GAAP financial measure, is annual revenue as reported in the Company’s publicly filed financial statements, adjusted to exclude variances attributable to fluctuations in foreign exchange rates (i.e., on a constant currency basis).
Company Selected Measure Name |  |  | Adjusted revenue |  |  |  |
Named Executive Officers, Footnote |  |  |
(1) | During 2022, both Mr. Hollingshead and Ms. Petrovic served as Insulet’s Principal Executive Officer (PEO) for a portion of the year. Mr. Hollingshead (“PEO1”) served as PEO from June 1, 2022 to April 28, 2025 and Ms. Petrovic (PEO2) served as PEO in 2020, 2021, and, from January 1, 2022 to June 1, 2022.
(2) | These amounts represent compensation set forth in the “Total” column of the Summary Compensation Table for our PEO and an average of the Summary Compensation totals for the following named executive officers (“NEOs”) for the years indicated:
| Year |  |  | PEO |  |  | Non-PEO NEOs |
| 2024 |  |  | James Hollingshead |  |  | Ana Chadwick, Eric Benjamin, John Kapples, Mark Field, Lauren Budden |
| 2023 |  |  | James Hollingshead |  |  | Lauren Budden, Eric Benjamin, John Kapples, Mark Field, Wayde McMillan, Bret Christensen |
| 2022 |  |  | James Hollingshead Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, Eric Benjamin |
| 2021 |  |  | Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, John Kapples |
| 2020 |  |  | Shacey Petrovic |  |  | Wayde McMillan, Charles Alpuche, Bret Christensen, Dan Manea |
Adjustment To PEO Compensation, Footnote |  |  |
(4) | The table below reflects the amounts deducted and added to the Summary Compensation Table total compensation in order to determine compensation actually paid, as defined and computed in accordance with SEC rules.
| Executive |  |  | Fiscal Year |  |  | Total Reported in Summary Compensation Table |  |  | - Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year |  |  | + Fair Value at Fiscal Year- End of Outstanding and Unvested Option Awards and Stock Awards Granted in 2024 |  |  | + Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years |  |  | + Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year |  |  | - Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions during Fiscal Year(a) |  |  | Compensation Actually Paid |
| James Hollingshead (CEO/PEO)(b) |  |  | 2024 |  |  | $13,302,350 |  |  | ($10,249,856) |  |  | $25,478,850 |  |  | $4,713,605 |  |  | ($537,180) |  |  | $0 |  |  | $32,707,769 |
|  |  |  | 2023 |  |  | $12,379,765 |  |  | ($9,499,797) |  |  | $11,615,643 |  |  | ($1,533,273) |  |  | ($158,475) |  |  | $0 |  |  | $12,803,863 |
|  |  |  | 2022 |  |  | $10,817,028 |  |  | ($8,999,878) |  |  | $14,245,170 |  |  | $0 |  |  | $0 |  |  | $0 |  |  | $16,062,320 |
| Shacey Petrovic (PEO2) |  |  | 2022 |  |  | $15,711,252 |  |  | ($14,006,044) |  |  | $11,115,887 |  |  | $1,586,091 |  |  | ($911,486) |  |  | $0 |  |  | $13,495,700 |
|  |  |  | 2021 |  |  | $9,723,273 |  |  | ($7,999,379) |  |  | $7,011,866 |  |  | ($692,234) |  |  | ​$1,077,356 |  |  | $0 |  |  | $9,120,882 |
|  |  |  | 2020 |  |  | $7,275,332 |  |  | ($5,476,105) |  |  | $7,347,782 |  |  | $6,876,682 |  |  | $2,831,971 |  |  | $0 |  |  | $18,855,662 |
| Average for Other NEOs |  |  | 2024 |  |  | $3,341,659 |  |  | ($2,289,749) |  |  | $5,179,609 |  |  | $443,080 |  |  | ($121,153) |  |  | $0 |  |  | $6,553,447 |
|  |  |  | 2023 |  |  | $2,840,156 |  |  | ($1,835,437) |  |  | $1,003,036 |  |  | ($240,497) |  |  | $115,240 |  |  | ($1,531,286) |  |  | $351,212 |
|  |  |  | 2022 |  |  | $3,375,872 |  |  | ($2,274,727) |  |  | $2,984,865 |  |  | $450,758 |  |  | ($292,425) |  |  | $0 |  |  | $4,244,342 |
|  |  |  | 2021 |  |  | $2,585,706 |  |  | ($1,674,745) |  |  | $1,484,500 |  |  | ($55,242) |  |  | $272,828 |  |  | $0 |  |  | $2,613,046 |
|  |  |  | 2020 |  |  | $2,363,796 |  |  | ($1,418,526) |  |  | $1,934,038 |  |  | $2,034,349 |  |  | $456,672 |  |  | $0 |  |  | $5,370,327 |
(a) | Messrs. Christensen and McMillan left the Company on May 5, 2023 and October 20, 2023, respectively. Their outstanding unvested stock awards and option awards were forfeited in 2023 and will not be realized.
(b) | Mr. Hollingshead left the Company in April 2025.
Non-PEO NEO Average Total Compensation Amount |  |  | $ 3,341,659 | $ 2,840,156 | $ 3,375,872 | $ 2,585,706 | $ 2,363,796
Non-PEO NEO Average Compensation Actually Paid Amount |  |  | $ 6,553,447 | 351,212 | 4,244,342 | 2,613,046 | 5,370,327
Adjustment to Non-PEO NEO Compensation Footnote |  |  |
(4) | The table below reflects the amounts deducted and added to the Summary Compensation Table total compensation in order to determine compensation actually paid, as defined and computed in accordance with SEC rules.
| Executive |  |  | Fiscal Year |  |  | Total Reported in Summary Compensation Table |  |  | - Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year |  |  | + Fair Value at Fiscal Year- End of Outstanding and Unvested Option Awards and Stock Awards Granted in 2024 |  |  | + Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years |  |  | + Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year |  |  | - Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions during Fiscal Year(a) |  |  | Compensation Actually Paid |
| James Hollingshead (CEO/PEO)(b) |  |  | 2024 |  |  | $13,302,350 |  |  | ($10,249,856) |  |  | $25,478,850 |  |  | $4,713,605 |  |  | ($537,180) |  |  | $0 |  |  | $32,707,769 |
|  |  |  | 2023 |  |  | $12,379,765 |  |  | ($9,499,797) |  |  | $11,615,643 |  |  | ($1,533,273) |  |  | ($158,475) |  |  | $0 |  |  | $12,803,863 |
|  |  |  | 2022 |  |  | $10,817,028 |  |  | ($8,999,878) |  |  | $14,245,170 |  |  | $0 |  |  | $0 |  |  | $0 |  |  | $16,062,320 |
| Shacey Petrovic (PEO2) |  |  | 2022 |  |  | $15,711,252 |  |  | ($14,006,044) |  |  | $11,115,887 |  |  | $1,586,091 |  |  | ($911,486) |  |  | $0 |  |  | $13,495,700 |
|  |  |  | 2021 |  |  | $9,723,273 |  |  | ($7,999,379) |  |  | $7,011,866 |  |  | ($692,234) |  |  | ​$1,077,356 |  |  | $0 |  |  | $9,120,882 |
|  |  |  | 2020 |  |  | $7,275,332 |  |  | ($5,476,105) |  |  | $7,347,782 |  |  | $6,876,682 |  |  | $2,831,971 |  |  | $0 |  |  | $18,855,662 |
| Average for Other NEOs |  |  | 2024 |  |  | $3,341,659 |  |  | ($2,289,749) |  |  | $5,179,609 |  |  | $443,080 |  |  | ($121,153) |  |  | $0 |  |  | $6,553,447 |
|  |  |  | 2023 |  |  | $2,840,156 |  |  | ($1,835,437) |  |  | $1,003,036 |  |  | ($240,497) |  |  | $115,240 |  |  | ($1,531,286) |  |  | $351,212 |
|  |  |  | 2022 |  |  | $3,375,872 |  |  | ($2,274,727) |  |  | $2,984,865 |  |  | $450,758 |  |  | ($292,425) |  |  | $0 |  |  | $4,244,342 |
|  |  |  | 2021 |  |  | $2,585,706 |  |  | ($1,674,745) |  |  | $1,484,500 |  |  | ($55,242) |  |  | $272,828 |  |  | $0 |  |  | $2,613,046 |
|  |  |  | 2020 |  |  | $2,363,796 |  |  | ($1,418,526) |  |  | $1,934,038 |  |  | $2,034,349 |  |  | $456,672 |  |  | $0 |  |  | $5,370,327 |
(a) | Messrs. Christensen and McMillan left the Company on May 5, 2023 and October 20, 2023, respectively. Their outstanding unvested stock awards and option awards were forfeited in 2023 and will not be realized.
(b) | Mr. Hollingshead left the Company in April 2025.
Compensation Actually Paid vs. Total Shareholder Return |  |  | The following graph compares the compensation actually paid to our PEOs and the average of compensation actually paid to our remaining NEOs with the performance of our common stock and the performance of the Nasdaq Healthcare Index (“IXHC”). The total shareholder return (“TSR”) of our stock and the IXHC TSR assume that $100 was invested beginning on December 31, 2019. The TSR of our stock declined from December 31, 2022 to December 31, 2023 then recovered from December 31, 2023 to December 31, 2024. PEO and Average NEO compensation follows a similar pattern for that period; declining from December 31, 2022 to December 31, 2023 before recovering from December 31, 2023 to December 31, 2024. Additionally, the Company’s TSR since December 31, 2019 was positive and higher than that of the Nasdaq Healthcare Index for the same period. |  |  |  |
Compensation Actually Paid vs. Net Income |  |  | The following graph compares the compensation actually paid to our PEOs and the average of compensation actually paid to our remaining NEOs with our net income. The Company’s net income increased considerably from 2023 to 2024. Compensation also increased from 2023 to 2024. Net income is not a financial measure used by our Talent and Compensation Committee to link compensation actually paid to our NEOs to company performance. |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  | The following graph compares the compensation actually paid to our PEOs and the average compensation actually paid to our remaining NEOs with our adjusted revenue. The Company’s adjusted revenue increased considerably from 2023 to 2024. Compensation also increased from 2023 to 2024. As noted above, Adjusted Revenue is one of the most important financial measures used to link compensation actually paid to our NEOs to company performance and is the most heavily weighted measure in the Annual Incentive Plan as well as for our PSUs. |  |  |  |
Total Shareholder Return Vs Peer Group |  |  | The following graph compares the compensation actually paid to our PEOs and the average of compensation actually paid to our remaining NEOs with the performance of our common stock and the performance of the Nasdaq Healthcare Index (“IXHC”). The total shareholder return (“TSR”) of our stock and the IXHC TSR assume that $100 was invested beginning on December 31, 2019. The TSR of our stock declined from December 31, 2022 to December 31, 2023 then recovered from December 31, 2023 to December 31, 2024. PEO and Average NEO compensation follows a similar pattern for that period; declining from December 31, 2022 to December 31, 2023 before recovering from December 31, 2023 to December 31, 2024. Additionally, the Company’s TSR since December 31, 2019 was positive and higher than that of the Nasdaq Healthcare Index for the same period. |  |  |  |
Tabular List, Table |  |  | Narrative to Pay versus Performance Table For the fiscal year ended December 31, 2024, the most important (and only) financial performance measures used to link compensation actually paid to our NEOs to company performance were Adjusted Revenue and Adjusted EBIT. As discussed in the “Compensation Discussion and Analysis” (“CD&A”) section of the proxy statement, these measures are used in our Annual Incentive Plan as well as for our PSUs issued under our Long-Term Equity Incentive Plan. For our 2024 Annual Incentive Plan, we also utilized non-financial strategic measures, as described in the CD&A.
| Important Financial Performance Measures |
| Adjusted Revenue |
| Adjusted EBIT |
Total Shareholder Return Amount |  |  | $ 152.49 | 126.74 | 171.96 | 155.41 | 149.32
Peer Group Total Shareholder Return Amount |  |  | 105.42 | 106.34 | 99.81 | 125.43 | 130.04
Net Income (Loss) |  |  | $ 418,300,000 | $ 206,300,000 | $ 4,600,000 | $ 16,800,000 | $ 6,800,000
Company Selected Measure Amount |  |  | 2,074,100,000 | 1,689,300,000 | 1,331,000,000 | 1,091,900,000 | 897,000,000
PEO Name | Shacey Petrovic | James Hollingshead | James Hollingshead | James Hollingshead |  | Shacey Petrovic | Shacey Petrovic
Measure:: 1 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Adjusted Revenue |  |  |  |
Non-GAAP Measure Description |  |  |
(6) | Adjusted revenue is Insulet’s self-selected most important financial metric used to determine compensation actually paid in the most recent fiscal year. Adjusted revenue, which is a non-GAAP financial measure, is annual revenue as reported in the Company’s publicly filed financial statements, adjusted to exclude variances attributable to fluctuations in foreign exchange rates (i.e., on a constant currency basis).
Measure:: 2 |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Name |  |  | Adjusted EBIT |  |  |  |
James Hollingshead [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  | $ 13,302,350 | $ 12,379,765 | $ 10,817,028 |  |
PEO Actually Paid Compensation Amount |  |  | 32,707,769 | 12,803,863 | 16,062,320 |  |
Shacey Petrovic [Member] |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
PEO Total Compensation Amount |  |  |  |  | 15,711,252 | $ 9,723,273 | $ 7,275,332
PEO Actually Paid Compensation Amount |  |  |  |  | 13,495,700 | 9,120,882 | 18,855,662
PEO | James Hollingshead [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (10,249,856) | (9,499,797) | (8,999,878) |  |
PEO | James Hollingshead [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 25,478,850 | 11,615,643 | 14,245,170 |  |
PEO | James Hollingshead [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 4,713,605 | (1,533,273) | 0 |  |
PEO | James Hollingshead [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (537,180) | (158,475) | 0 |  |
PEO | James Hollingshead [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 0 | 0 | 0 |  |
PEO | Shacey Petrovic [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | (14,006,044) | (7,999,379) | (5,476,105)
PEO | Shacey Petrovic [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | 11,115,887 | 7,011,866 | 7,347,782
PEO | Shacey Petrovic [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | 1,586,091 | (692,234) | 6,876,682
PEO | Shacey Petrovic [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | (911,486) | 1,077,356 | 2,831,971
PEO | Shacey Petrovic [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  | 0 | 0 | 0
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (2,289,749) | (1,835,437) | (2,274,727) | (1,674,745) | (1,418,526)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 5,179,609 | 1,003,036 | 2,984,865 | 1,484,500 | 1,934,038
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 443,080 | (240,497) | 450,758 | (55,242) | 2,034,349
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | (121,153) | 115,240 | (292,425) | 272,828 | 456,672
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year |  |  |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |  |  |
Adjustment to Compensation, Amount |  |  | $ 0 | $ (1,531,286) | $ 0 | $ 0 | $ 0

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=podd_JamesHollingsheadMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=podd_ShaceyPetrovicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |